Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about COMT: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
COMT is a protein involved in neurodegeneration research. Key relationships include: associated with, expressed in, co discussed. Associated with ALS, ALZHEIMER'S, ALZHEIMER'S DISEASE. Connected to 173 entities in the SciDEX knowledge graph.
| Gene Symbol | COMT |
| Full Name | Catechol-O-Methyltransferase |
| Chromosome | 22 |
| Protein Type | Enzyme |
| Function | The COMT gene encodes catechol-O-methyltransferase, an enzyme that catalyzes the methylation of catecholamines using S-adenosylmethionine (SAM) as a methyl donor. |
| Primary Expression | peripheral tissues |
| Molecular Weight | 30 kDa |
| Pathways | autophagy pathway |
| UniProt ID | P21964 |
| Ensembl ID | ENSG00000093072 |
| OMIM | 116790 |
| GeneCards | COMT |
| Human Protein Atlas | COMT |
| Associated Diseases | ALS, Alzheimer, Alzheimer'S Disease, Anxiety |
| Known Drugs/Compounds | levodopa, LEVODOPA |
| Interactions | SLC6A4, GBA3, SLC22A2, DRD2, SLC6A3, GENES |
| KG Connections | 276 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
COMT["COMT Gene<br/>Catechol-O-methyltransferase"]
COMT_protein["COMT Protein<br/>Dopamine Metabolizing<br/>Enzyme"]
dopamine["Dopamine<br/>Neurotransmitter"]
cognitive_function["Cognitive Function<br/>Executive Control<br/>Working Memory"]
SLC6A3["DAT1 (SLC6A3)<br/>Dopamine Transporter"]
SLC6A2["NET (SLC6A2)<br/>Norepinephrine Transporter"]
ADRA2A["ADRA2A<br/>Alpha-2A Adrenergic<br/>Receptor"]
HTR2C["HTR2C<br/>Serotonin 2C Receptor"]
Alzheimer["Alzheimer's Disease<br/>Cognitive Decline"]
Parkinson["Parkinson's Disease<br/>Motor and Cognitive<br/>Dysfunction"]
ALS["ALS<br/>Motor Neuron<br/>Degeneration"]
Depression["Depression<br/>Mood Disorder"]
Dementia["Dementia<br/>Progressive<br/>Cognitive Loss"]
COMT --|"encodes"|--> COMT_protein
COMT_protein --|"metabolizes"|--> dopamine
dopamine --|"regulates"|--> cognitive_function
COMT --|"variants affect"|--> Alzheimer
COMT --|"variants affect"|--> Parkinson
COMT --|"contributes to"|--> ALS
COMT --|"associated with"|--> Depression
COMT --|"therapeutic target"|--> Dementia
SLC6A3 --|"interacts with"|--> dopamine
SLC6A2 --|"modulates"|--> COMT_protein
ADRA2A --|"influences"|--> cognitive_function
HTR2C --|"cross-regulates"|--> dopamine
cognitive_function --|"impaired in"|--> Alzheimer
cognitive_function --|"affected in"|--> Parkinson
dopamine --|"depleted in"|--> Parkinson
style COMT fill:#006494
style COMT_protein fill:#006494
style dopamine fill:#4a1a6b
style cognitive_function fill:#1b5e20
style SLC6A3 fill:#4a1a6b
style SLC6A2 fill:#4a1a6b
style ADRA2A fill:#4a1a6b
style HTR2C fill:#4a1a6b
style Alzheimer fill:#ef5350
style Parkinson fill:#ef5350
style ALS fill:#ef5350
style Depression fill:#ef5350
style Dementia fill:#ef5350| Target | Relation | Type | Str |
|---|---|---|---|
| Levodopa-Induced Dyskinesia | risk_factor_for | phenotype | 0.95 |
| Levodopa Response | biomarker_for | phenotype | 0.90 |
| Signal Transmission | involved_in | process | 0.90 |
| Parkinson Disease | associated_with | disease | 0.90 |
| Metabolite Levels | regulates | phenotype | 0.85 |
| Cognition | regulates | phenotype | 0.85 |
| Levodopa-induced dyskinesia | risk_factor_for | phenotype | 0.85 |
| Chemical synaptic transmission | modulates | process | 0.82 |
| hyperuricemia | inhibits | disease | 0.80 |
| glioma | associated_with | disease | 0.80 |
| Cognitive Aging | risk_factor_for | phenotype | 0.80 |
| DRD2 | interacts_with | gene | 0.80 |
| dopamine | degrades | entity | 0.80 |
| Parkinson's disease | associated_with | disease | 0.80 |
| anxiety | modulates | phenotype | 0.75 |
| Parkinson | associated_with | disease | 0.75 |
| Als | associated_with | disease | 0.75 |
| Dementia | associated_with | disease | 0.75 |
| Parkinson'S Disease | associated_with | disease | 0.75 |
| Parkinson's Disease | implicated_in | disease | 0.75 |
| COMT_protein | encodes | protein | 0.72 |
| cognitive_function | associated_with | phenotype | 0.72 |
| age-related cognitive decline | associated_with | phenotype | 0.70 |
| Parkinson's disease | biomarker_for | disease | 0.70 |
| Alzheimer | associated_with | disease | 0.65 |
| Dementia | therapeutic_target | disease | 0.65 |
| Depression | associated_with | disease | 0.65 |
| Anxiety | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Hypertension | associated_with | disease | 0.65 |
| Als | contributes_to | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Dementia | interacts_with | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| ALS | contributes_to | disease | 0.65 |
| Infection | associated_with | disease | 0.65 |
| dopamine | regulates | protein | 0.64 |
| NBEA | associated_with | gene | 0.60 |
| HTR2C | associated_with | gene | 0.60 |
| ADRA2A | associated_with | gene | 0.60 |
| BCHE | associated_with | gene | 0.60 |
| SLC6A2 | associated_with | gene | 0.60 |
| SLC6A3 | associated_with | gene | 0.60 |
| ABCB1 | associated_with | gene | 0.60 |
| SLC6A4 | associated_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| levodopa | targets | drug | 0.70 |
| PARKINSON'S DISEASE | associated_with | gene | 0.70 |
| PARKINSON | associated_with | gene | 0.70 |
| LEVODOPA | activates | drug | 0.70 |
| MAOB | associated_with | gene | 0.60 |
| GABRA1 | associated_with | gene | 0.60 |
| CHAT | associated_with | gene | 0.60 |
| CYP2D6 | associated_with | gene | 0.60 |
| APOE | associated_with | gene | 0.60 |
| HMGCR | associated_with | gene | 0.60 |
| OPRM1 | associated_with | gene | 0.60 |
| SLC30A8 | associated_with | gene | 0.60 |
| DRD2 | associated_with | gene | 0.60 |
| FYN | associated_with | gene | 0.60 |
| SRC | associated_with | gene | 0.60 |
| CAMK2A | associated_with | gene | 0.60 |
| SNCA | associated_with | gene | 0.60 |
| SLC6A3 | associated_with | gene | 0.60 |
| UBC | associated_with | gene | 0.60 |
| HOMER1 | associated_with | gene | 0.60 |
| GBA3 | associated_with | gene | 0.60 |
| BDNF | contributes_to | gene | 0.60 |
| BCHE | associated_with | gene | 0.60 |
| ADRA2A | associated_with | gene | 0.60 |
| ADRB2 | associated_with | gene | 0.60 |
| GSTP1 | associated_with | gene | 0.60 |
| ABCB1 | associated_with | gene | 0.60 |
| APOE | co_discussed | gene | 0.60 |
| CHAT | co_discussed | gene | 0.60 |
| BDNF | co_discussed | gene | 0.60 |
| PENK | expressed_in | gene | 0.60 |
| NCAM1 | expressed_in | gene | 0.60 |
| DNMT1 | expressed_in | gene | 0.60 |
| AKT1 | expressed_in | gene | 0.60 |
| MTOR | associated_with | gene | 0.60 |
| IGF2R | associated_with | gene | 0.60 |
| CAV1 | associated_with | gene | 0.60 |
| SLC6A4 | expressed_in | gene | 0.60 |
| DICER1 | expressed_in | gene | 0.60 |
| NR3C1 | expressed_in | gene | 0.60 |
| IL1B | expressed_in | gene | 0.60 |
| NBEA | associated_with | gene | 0.60 |
| HTR2C | associated_with | gene | 0.60 |
| CYP3A4 | associated_with | gene | 0.60 |
| SLC6A3 | causes | gene | 0.60 |
| SLC6A2 | associated_with | gene | 0.60 |
| SLC6A4 | associated_with | gene | 0.60 |
| SLC22A2 | associated_with | gene | 0.60 |
| LRRK2 | associated_with | gene | 0.60 |
| SNCA | causes | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||